Hereditary leiomyomatosis and renal cell cancer: An unusual and aggressive form of hereditary renal carcinoma

Nature Clinical Practice Oncology

Volumn 4, Issue 4, 2007, Pages 256-261

  Al Refae, Munir ^a   Wong, Nora ^a   Patenaude, François ^a   Bégin, Louis R ^c   Foulkes, William D ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FUMARATE HYDRATASE; INTERFERON; INTERLEUKIN 2; IROFULVEN; TOPOTECAN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CANCER IMMUNOTHERAPY; CASE REPORT; CHROMOSOME 1; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FAMILY HISTORY; FATIGUE; FEBRILE NEUTROPENIA; GENE MUTATION; GENETIC COUNSELING; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LEIOMYOMATOSIS; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; UNINEPHRECTOMY; WEIGHT REDUCTION;

ADOLESCENT; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; FUMARATE HYDRATASE; HUMANS; KIDNEY NEOPLASMS; LEIOMYOMATOSIS; MALE; MUTATION;

EID: 34047103477     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0773     Document Type: Article

References (20)

1. Amato RJ et al. (2002) Irofulven, a novel inhibitor of DNA synthesis, in metastatic renal cell cancer. Invest New Drugs 20: 413-417
2. Tomlinson IP et al. (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30: 406-410
3. Launonen V et al. (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98: 3387-3392
4. Linehan WM et al. (2003) The genetic basis of cancer of the kidney. J Urol 170: 2163-2172
5. Knudson AG (1997) Hereditary predisposition to cancer. Ann N Y Acad Sci 833: 58-67
6. Zbar B et al. (2003) Studying cancer families to identify kidney cancer genes. Annu Rev Med 54: 217-233
7. Abdulrahman M et al. (2006) Identification of novel VHL targets that are associated with the development of renal cell carcinoma. Oncogene [doi: 10.1038/sj.onc. 1209932]
8. Reed WB et al. (1973) Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 53: 409-416
9. Toro JR et al. (2003) Mutations in the fumarate hydratase gone cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73: 95-106
10. Wei MH et al. (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43: 18-27
11. Alam NA et al. (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12: 1241-1252
12. Lehtonen HJ et al. (2006) Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43: 523-526
13. Alam NA et al. (2005) Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol 153: 11-17
14. Isaacs JS et al. (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability. Cancer Cell 8: 143-153
15. Brugarolas J (2007) Renal-cell carcinoma - molecular pathways and therapies. N Engl J Med 356: 185-187
16. Gellera C et al. (1990) Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes. Neurology 40: 495-499
17. Kiuru M et al. (2002) Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 62: 4554-4557
18. Pithukpakorn M et al. (2006) Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43: 755-762
19. Alam M et al. (2002) Gabapentin treatment of multiple piloleiomyoma-related pain. J Am Acad Dermatol 46 (Suppl): S27-S29
20. Choyke PL et al. (1997) Imaging features of hereditary papillary renal cancers. J Comput Assist Tomogr 21: 737-741